Related Experiment Video

Updated: Jul 13, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.6K

[Receptor tyrosine kinase- fusions in paediatric spindle cell tumors]

Christiane Brenner1, Christine Sanders2, Christian Vokuhl3

  • 1Sektion Kinderpathologie, Institut für Pathologie, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. christiane.brenner@ukbonn.de.

Pathologie (Heidelberg, Germany)
|October 11, 2023
PubMed

Insights

Pediatric spindle cell tumors are challenging to diagnose. Identifying receptor tyrosine kinase fusions, such as NTRK, ALK, RET, and ROS1, aids in classifying these rare tumors and offers potential targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Context:

  • Pediatric spindle cell tumors represent a rare and diagnostically challenging group of neoplasms.
  • Their similar morphology and non-specific immunohistochemical profiles complicate accurate diagnosis.
  • Advances in genetic characterization have led to the identification of novel subgroups, influencing WHO classifications.

Purpose:

  • To highlight the diagnostic and therapeutic significance of receptor tyrosine kinase (RTK) fusions in pediatric spindle cell tumors.
  • To underscore the role of genetic profiling in refining tumor classification and guiding treatment strategies.

Summary:

  • Receptor tyrosine kinase fusions, particularly involving NTRK1-3, ALK, RET, and ROS1, are crucial in specific pediatric spindle cell tumors.
  • Verification of these genetic alterations is diagnostically relevant and supports the development of targeted therapies.
  • These RTK-fusion-positive tumors are often low-grade and fall into the intermediate-malignancy category.

Impact:

  • Improved diagnostic accuracy for rare pediatric spindle cell tumors.
  • Identification of actionable targets for personalized, therapy-oriented treatments.
  • Enhanced understanding of the molecular landscape of pediatric spindle cell neoplasms.
Keywords:
Anaplastic lymphoma kinaseFibrosarcomaHigh-throughput nucleotide sequencingHuman ROS1 proteinMolecular targeted therapy

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.8K

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K